Serkan Yazman

Dr. Serkan Yazman

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2019 in Turkish Journal of Anesthesia and Reanimation
Verified
Journal Article
Closed access
MYMihriban Yalcin
Mihriban Yalcin
EGEda Godekmerdan
Eda Godekmerdan
KTKaptani Derya Tayfur
Kaptani Derya Tayfur
SYSerkan Yazman
Serkan Yazman
MUMelih Urkmez
Melih Urkmez
YAYusuf Ata
Yusuf Ata
The Acute Physiology and Chronic Health Evaluation (APACHE) severity of disease classification system, which is one of the most widely used scoring systems to predict mortality, is used for intensive care units (ICU) patients. This study aimed to evaluate the predictive ability of APACHE II for mortality in patients after undergoing cardiac surgery. We studied if APACHE II could successfully predict the outcome in post-cardiac surgery patients. This study involved retrospective data collection of all adult patients who were admitted to Ordu State Hospital cardiovascular surgery ICU following cardiac surgery from August 2013 to December 2015. Area under the receiver operating characteristic (ROC) curve (AUC) values were calculated for the APACHE II model. During the two years of data collection, we included 600 patients with a mean age of 64.77±10.148 years. Of these, 180 (30.0%) were females. The ICU mortality rate was 8.33%, and the mean length of ICU stay was 4.210±6.913 days. The mean pre-operative EuroSCORE was 3.890±2.565, and the mean pre-operative APACHE II score was 6.790±3.617. The AUC values for APACHE II and EuroSCORE were 0.743 and 0.767, respectively. The APACHE II model can be used to predict mortality in a Turkish population of patients who have undergone cardiac surgery.

3 April 2023 in Angiology
Verified
Journal Article
Closed access
SYSerkan Yazman
Serkan Yazman
BDBurak Can Depboylu
Burak Can Depboylu
ESErcan Saruhan
Ercan Saruhan
UCUtku Cenikli
Utku Cenikli
BHBuğra Harmandar
Buğra Harmandar
HIHande İşTar
Hande İşTar
The present study evaluated the use of endocan, interleukin-17 (IL-17), and thrombospondin-4 (TSP-4) blood levels as potential biomarkers for the diagnosis and follow-up of peripheral arterial disease (PAD). Patients with PAD (Rutherford categories I, II, and III) who were admitted between March 2020 and March 2022 for cardiovascular surgery or outpatient clinic follow-up were included. The patients ( n = 60) were divided into 2 groups: medical treatment ( n = 30) and surgical treatment ( n = 30). In addition, a control group ( n = 30) was created for comparison. Endocan, IL-17, and TSP-4 blood levels were measured at the time of diagnosis and at the first month after treatment. Endocan and IL-17 values were found to be significantly higher in both groups that underwent medical (259.7 ± 46 pg/mL, 63.7 ± 16.6 pg/mL) and surgical (290.3 ± 84.5 pg/mL, 66.4 ± 19.6 pg/mL) treatment than the control group (187.4 ± 34.5 pg/mL, 56.5 ± 7.2 pg/mL P < .001). Tsp-4 value was found to be significantly higher only in the surgical treatment group (15 ± 4.3 ng/mL) than the control group (12.9 ± 1.4 ng/mL P < .05). The decreases in endocan, IL-17, and TSP-4 levels at the first month of treatment in both groups were also significant ( P < .001). A combination of classical and these new biomarkers could be included in PAD screening, early diagnosis, severity determination, and follow-up protocols in order to provide effective assessment in clinical practice.

6 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ŞİŞahin İşcan
Şahin İşcan
EKErturk Karaagac
Erturk Karaagac
NTNuri Utkan Tunca
Nuri Utkan Tunca
HSHacı anıl solak
Hacı anıl solak
HIHasan Iner
Hasan Iner
AGAli Gürbüz
Ali Gürbüz
Background/Objectives: Delayed sternal closure (DSC) is a useful management strategy for complex cardiac interventions. The aim of this study was to investigate the patients who had DSC in our clinic over a 12-year period and to evaluate the postoperative results. Methods: A total of 124 DSC patients from a total cardiac surgery practice during a 12-year period (n = 6532, 1.8%, between January 2014 and September 2025) were retrospectively analyzed. Preoperative and intraoperative patient characteristics, morbidities, and mortality rates were collected and compared with the group undergoing primary sternal closure (PSC), which were matched with the DSC group in terms of preoperative and intraoperative patient characteristics. Results: A total of 124 (1.8%) patients required DSC, and 33.1% of the patients were females. The indications were bleeding (n = 81, 65%) and hemodynamic instability (n = 43, 35%). Total bypass times, cross-clamp times, and CPB temperature were higher in patients with DSC. A higher rate of inotropic support, intra-aortic balloon pump, extracorporeal lung support, blood transfusion, and bleeding were found in the DSC group. There was no difference in terms of sternal infection rate (2.4%). Intensive care unit stay, hospital stay, and mortality rate were also significantly increased in patients with DSC. Mortality rate in the DSC group was 16.1%. Conclusions: Multiple sternum revisions due to bleeding and low cardiac output syndrome may lead to increased mortality in high-risk patients. Planned postponement of sternal closure in these high-risk cardiac surgery patients helps to reduce perioperative morbidity and mortality.

2 November 2018 in The Annals of Thoracic Surgery
Verified
Journal Article
Open access
PDF file
HCHabib Cakir
Habib Cakir
IYIsmail Yurekli
Ismail Yurekli
HIHasan Iner
Hasan Iner
SYSerkan Yazman
Serkan Yazman
MKMert Kestelli
Mert Kestelli

27 June 2020 in The Journal of Vascular Access
Verified
Journal Article
Closed access
PDF file
BDBurak Can Depboylu
Burak Can Depboylu
SYSerkan Yazman
Serkan Yazman
After cancer diagnosis, patients often look to Internet to learn more about totally implantable venous access ports which improve compliance with systemic anticancer therapy, as they do not get enough information from healthcare professionals. The aim of this study was to evaluate the video quality on Internet about totally implantable venous access ports using the most used three Internet search engines worldwide. ‘Videos’ sections of the most used three Internet search engines were queried using ‘Chemotherapy Port’, ‘Port Catheter’ and ‘Totally Implantable Venous Access Ports’ keywords. First, 50 results of each keyword in each search engine were analysed and evaluated according to a novel scoring system created by authors (totally implantable venous access port video evaluation score), Journal of the American Medical Association score and modified DISCERN score by independent reviewers. Obtained data were analysed by descriptive statistics, Kruskal–Wallis and chi-square tests. Of the 450 videos, 229 were evaluated. The total video length was 1394.38 min. The mean video length was 6.08 ± 5.39 min, and the mean video view count was 32,553.71 ± 83,524.23. Mean Journal of the American Medical Association score, modified DISCERN score and totally implantable venous access port video evaluation score were 2.33 ± 0.90, 2.43 ± 1.59 and 3.54 ± 3.47, respectively. According to totally implantable venous access port video evaluation score, of the videos, 1.3% were remarkable, 5.2% were useful, 25.8% were poor and 67.7% were useless. Of the videos, 36.7% have been presented by healthcare professionals. Mean Journal of the American Medical Association score, modified DISCERN score and totally implantable venous access port video evaluation score of these videos were 3.11 ± 0.68, 3.97 ± 0.93 and 4.69 ± 4.25, respectively (p = 0.000, p = 0.000 and p = 0.003, respectively). Internet search engines’ ‘Videos’ sections have the potential of providing information about totally implantable venous access ports. However, they are vulnerable to providing unreliable information. This study has showed that videos about totally implantable venous access ports are insufficient in terms of reliability and integrity and may mislead patients.

1 October 2025 in Turkish Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
IYIsmail Yurekli
Ismail Yurekli
HIHasan İnEr
Hasan İnEr
SYSerkan Yazman
Serkan Yazman
OGOrhan Gökalp
Orhan Gökalp
HÇHabib Çakır
Habib Çakır
AGAli Gürbüz
Ali Gürbüz
Background: This study aims to examine factors influencing mortality and reintervention among endovascular aortic aneurysm repair patients treated over nearly two decades in the first hybrid operating room of Türkiye. Methods: Between December 2006 and December 2020, a total of 372 patients (349 males, 23 females; mean age: 70.4±8.2 years; range, 45 to 89 years) who underwent endovascular aortic aneurysm repair were retrospectively analyzed. Independent predictors of 30-day, one-year, and five-year mortality rate were identified. The Kaplan-Meier analyses compared outcomes across surgical approaches and graft types. Results: Mortality rates were 6.5% at 30 days, 14.2% at one year, and 21.8% at five years. Multivariate analysis identified postoperative complications (hazard ratio [HR]=3.68, p=0.034), elevated creatinine (HR=1.58, p=0.004), prolonged intubation (HR=1.01, p<0.001), and increased blood transfusion volume (HR=1.17, p=0.003) as independent predictors of 30-day mortality. Advanced age emerged as a significant predictor of five-year mortality (HR=1.09, p<0.001). Elective procedures and bi-iliac grafts demonstrated significantly improved survival across all timeframes (p<0.001). Conclusion: This real-world analysis identifies several procedural and patient-related factors associated with mortality following endovascular aortic aneurysm repair. Postoperative care indicators consistently demonstrated stronger independent associations with mortality than anatomical or demographic factors, highlighting the importance of comprehensive perioperative care optimization in endovascular aortic aneurysm repair management.